Background: Electronic medical record (EMR) computed algorithms allow investigators to screen thousands of patient records to identify specific disease cases. No computed algorithms have been developed to detect all cases of human immunodeficiency virus (HIV) infection using administrative, laboratory, and clinical documentation data outside of the Veterans Health Administration. We developed novel EMR-based algorithms for HIV detection and validated them in a cohort of subjects in the Duke University Health System (DUHS). Methods: We created 2 novel algorithms to identify HIV-infected subjects. Algorithm 1 used laboratory studies and medications to identify HIV-infected subjects, whereas Algorithm 2 used International Classification of Diseases, Ninth Revision (ICD-9) codes, medications, and laboratory testing. We applied the algorithms to a wellcharacterized cohort of patients and validated both against the gold standard of physician chart review. We determined sensitivity, specificity, and prevalence of HIV between 2007 and 2011 in patients seen at DUHS. Results: A total of 172 271 patients were detected with complete data; 1063 patients met algorithm criteria for HIV infection. In all, 970 individuals were identified by both algorithms, 78 by Algorithm 1 alone, and 15 by Algorithm 2 alone. The sensitivity and specificity of each algorithm were 78% and 99%, respectively, for Algorithm 1 and 77% and 100% for Algorithm 2. The estimated prevalence of HIV infection at DUHS between 2007 and 2011 was 0.6%. Conclusions: EMR-based phenotypes of HIV infection are capable of detecting cases of HIV-infected adults with good sensitivity and specificity. These algorithms have the potential to be adapted to other EMR systems, allowing for the creation of cohorts of patients across EMR systems.
reviewing individual files, often requiring multiple individuals collaborating over long periods of time. 1 Compiling a large sample with a given disease or characteristic could take months and hundreds of person-hours using these traditional methods, limiting the ability of researchers to conduct important clinical studies. 1 With the advent and adoption of the EMR, researchers are now able to rapidly identify potential disease cases for clinical studies. [2] [3] [4] To do this effectively and fully leverage the benefits of an electronic system, computable phenotype algorithms are needed that can search across billing data, laboratory data, and clinical documentation in order to perform case detection. These computable phenotype algorithms can be conceived in a manner to have high sensitivity and specificity for identifying individual subjects' true disease status using methods borrowed from routine clinical care. [2] [3] [4] HIV infection is one disease that lends itself to this algorithmbased case detection, given the reliance on laboratory-based testing. 5 Previous studies that have attempted to identify HIV-infected patients in large datasets have had significant limitations. Many have focused on preselected populations, either Medicare and/or Medicaid enrollees [6] [7] [8] [9] or patients receiving care from the Veterans Health Administration. 10, 11 Due to their design, these studies lack generalizability outside the government health sector. Their utility is further limited by the use of administrative data alone for case detection, subjecting these studies to the systematic error inherent in this type of data, including missing codes if HIV infection is not the primary issue being addressed in an encounter, or inappropriate use of HIVrelated ICD-9 codes to cover diagnostic testing or HIV-prevention counseling. 12 Subsequent algorithms have improved on these methodologic issues, but were targeted to identify specific subgroups of patients, including foreign-born individuals who have known HIV infection 13 and only new cases of HIV infection in a dataset, 8 or determining which patients are not known to be infected with HIV but are at risk of contracting the disease. 14 In order to maximally utilize the features of the EMR to develop a virtual cohort of HIV-infected patients in a large nongovernmental dataset, we set out to develop novel computable phenotype algorithms for case detection of these patients. We also sought to validate the algorithms, determine their sensitivity and specificity, and use them to determine the prevalence of HIV infection in a large preexisting cohort.
MATERIALS AND METHODS

Study setting
This study was performed within the Duke University Health System in Durham, North Carolina, using an existing, previously described cohort comprising all adults (18þ years old) who had encounters with the health system between 2007 and 2011 and could be identified as Durham County residents at the end of 2011. 15 Within this cohort, a total of 4 408 919 unique patient encounters with an average of 881 784 encounters per year were identified. Data were extracted using the Duke Enterprise Data Unified Content Explorer system, a proprietary, web-based tool designed to interface with the health system's central data repository. 16 Accessible data included clinical, billing, and demographic information for patients across the health system's 3 acute care hospitals as well as ambulatory primary care and specialty clinics. Information in the repository is updated in an ongoing prospective fashion, and includes encounter information preceding the implementation of Epic software as the institution's unified EMR. Data available after the cohort time period were also included. Approval for the study was provided by the Duke Institutional Review Board for Clinical Investigation (Pro00057348).
EMR definition -multiple pathways
In order to maximize the utility and performance characteristics of the algorithms, 2 separate algorithms utilizing complementary approaches to HIV case detection were created. A panel of physicians, including experts in the diagnosis and treatment of HIV infection, provided recommendations for the development of these algorithms and approved their final versions. Algorithm 1 ( Figure 1 ) is a laboratory-based approach modified from the HIV diagnostic algorithm in practice during the period of our cohort enrollment, from 2007 to 2011. 17 For Algorithm 1, the expert panel concluded that a diagnosis of HIV could be reasonably applied if a patient had 17 The second was HIV-specific medications in the patient's prescribed medication list. The addition of HIVspecific medications was felt to represent evidence of contact with a health care provider with expertise in HIV diagnosis and treatment.
Recognizing that some medications used to treat HIV infection are also used today for hepatitis B, we looked for medication combinations specific to HIV therapy (Table 1) . Monotherapy with lamivudine, emtricitabine, or tenofovir was thus not considered a positive HIV medication unless prescribed in combination with an additional drug. By excluding single drugs only, we recognize that we may have included HIV-negative patients on dual therapy with emtricitabine and tenofovir for pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP). Additionally, we were unable to exclude patients on triple therapy for PEP as we did not have access to prescription records. Algorithm 2 ( Figure 2 ) was designed to detect those patients not identified by Algorithm 1 due to incomplete medical records, because they had fragmented access to care or had diagnostic labs performed outside of the study's health system. Both of these scenarios led to HIV-infected patients not having results for all labs required for Algorithm 1 accessible within the study's health system. Algorithm 2, a complementary algorithm, includes a combination of ICD-9 billing codes, laboratory investigations, and medication lists to create a more "real-world" clinical approach to HIV case detection. Borrowing from traditional retrospective research methodology, Algorithm 2 begins with an ICD-9 code for an HIV-related illness (Table 2) , followed by a confirmatory medication list (Table  1) or lab test (HIV antibody, HIV Western blot, or HIV PCR).
Implementation
Once the 2 algorithms were finalized and approved by the physician panel, individual components of each algorithm were converted into programmable, searchable code. Given the evolving nature of data storage in the central repository over time due to changes in HIV testing technology and new medication development, a comprehensive search of the metadata was necessary to identify all permutations of pertinent laboratory results and medications. The Duke Enterprise Data Unified Content Explorer system was used for this search, and a list of all permutations of pertinent laboratory test names, ICD-9 codes, and medication names was compiled (Tables 1  and 2 ). ICD-9 codes were readily identified and implemented without the need for manual chart review. In contrast, searches for medication names and laboratory test names yielded thousands of results for a small number of pertinent items. The initial metadata search results were manually reviewed by the study team to isolate pertinent test and medication names. By initially reviewing at the metadata level (as opposed to the clinical documentation level), we were able to ensure that each unique lab value and medication label in our data extract was reviewed by a trained clinician in an efficient and systematic manner. In those cases where manual review of the metadata was insufficient to conclude the name of a laboratory test or medication, due either to misspelling during the clinical encounter documentation or formatting issues when transferring from clinical documentation to the data repository, manual chart review of the clinical documentation was performed.
Following the initial review of laboratory names, the list of pertinent permutations required a second manual review by study personnel in order to codify the results. For HIV antibody testing, only "positive" was considered to be positive, whereas "negative" and "indeterminate" were considered to be negative and did not contribute to a diagnosis. In rare instances, this approach does have the potential to introduce false negatives if the patient has acute HIV infection, as a positive HIV PCR may not have been performed if a negative or indeterminate HIV antibody test was recorded. For HIV PCR testing, we included both quantitative measures of HIV viral load and results from HIV genotyping and resistance pattern analyses as equivalent tests for case detection purposes. For viral load, a detectable level was considered "positive" regardless of level, and an undetectable level was considered "negative." This definition also has the potential to introduce false negatives, as an undetectable viral load can be seen in patients on effective antiretroviral therapy or in "elite controllers," HIV-infected persons with undetectable viremia off antiretrovirals. For genotyping, a reported result was considered to be "positive," as this test can only be performed when there is detectable HIV present.
Once all components of the 2 algorithms were codified, we applied the algorithms to the data for our study population. Data collected outside of the 5-year enrollment period for the cohort were included in the analysis for those subjects enrolled in the cohort.
Validation
Following implementation of our computed algorithms, a validation step was performed to determine test characteristics, including sensitivity and specificity. Additional information, including potential strengths and weaknesses of each algorithm, were also identified. The gold standard used for comparison in the validation step was physician manual chart review. Because the prevalence of HIV infection in the general population is low, simple random sampling from the entire population would require a prohibitively large sample size. In order to decrease the required sample size for a precision of 0.05% around our estimates, we stratified our population. We believe that the algorithms will perform differently across strata, and this performance variability drives the sampling scheme. Patients were stratified by the number of algorithms positive (both, one, or none), and those with no algorithm positive were further stratified by meeting any algorithm components as well as high vs low risk for HIV. High-risk individuals were defined as those with an ICD-9 code for hepatitis C, any sexually transmitted infection, or tuberculosis (see Supplementary Table A1 ). We then made assumptions for the true positive fraction and false positive fraction for each stratum. Our true positive fraction estimates were 0.975 for both algorithms positive and 1 algorithm positive strata, and 0.000 for single component positive, high-risk, and no component positive strata. Our false positive fraction estimates were 0.000 for both algorithms positive, 0.950 for 1 algorithm positive, 0.010 for single component positive and high risk, and 0.00000001 for no component positive strata. This estimate for 1 algorithm positive is high, signifying a strong belief in the independence of the algorithms to correctly identify HIV-infected individuals. Using these estimates, a stratified random sample size of 171 charts was selected to provide an overall point estimate for prevalence of HIV infection of 60.05%. Our sampling approach, designed to optimize estimation of sensitivity and specificity, naturally induces verification bias, 18 which we accounted for when estimating the operating characteristics of each phenotype by using methods from Begg and Greenes. 19 By reweighing our estimates at the stratum level to correspond to the weights derived in our sampling scheme, we corrected for the selection bias that we introduced. Simulation studies have been performed on these approximations for sample sizes of 100, 500, and 1000, with the coverage probabilities being close to the nominal level, which we expect should cover a sample size such as ours within this range. 19 Seven physician study team members participated in the review. Reviewers were given full access to the clinical EMRs of all patients, which included access to results posted prior to EMR implementation, as well as data linked to other health care systems via Epic's Care Everywhere function and to records scanned in from outside facilities that may not have been accessible by the algorithms. Charts were coded as definitely HIV-infected (positive HIV antibody or PCR), possibly HIV-infected (HIV on problem list plus HIV medication or 2þ infectious disease clinic notes with HIV as a diagnosis), or HIV-negative (not meeting the criteria for definite or possible). These criteria were approved by our physician panel in order to maximize specificity and minimize false positives. Each chart was reviewed separately by 2 investigators blinded to both the results of the algorithms and the decision of the other reviewer. All cases of disagreement were adjudicated by a third reviewer blinded in similar fashion to algorithm results and individual reviewer responses but unblinded as to status as a third reviewer for adjudication. Final HIV status was determined by the third reviewer in cases of disagreement. For the purpose of statistical analysis, a binary construct of "HIV-positive" and "HIV-negative" was created, with definitely and possibly HIVinfected results being combined into the "HIV-positive" category. The sensitivity and specificity of each algorithm was calculated with the chart review being treated as the gold standard.
RESULTS
Algorithms
We identified 172 271 individual patients with complete data, comprising our study population (Figure 3 ). An additional 1232 individuals had insufficient data to be included in the pool of participants. After applying the finalized algorithms to our data extract, we identified 1063 patients who met the criteria for the HIV-infected case definition. Seventy-eight were positive by Algorithm 1 alone, 15 were identified using Algorithm 2 alone, and 970 met the criteria for HIV infection by both algorithms. An additional 459 patients, as outlined in Figure 4 , had at least some positive component of the HIV algorithms but did not meet the full definition for being HIVinfected by either algorithm. Performance of each component of the 2 algorithms is outlined in Figure 4 , and details of the 459 patients with only a component positive are described in Table 3 . When utilized to detect cases of HIV infection in our cohort of subjects in DUHS, we found an estimated HIV prevalence of 0.6%.
Validation process
Comparing the results of our algorithms to the gold standard of clinician manual chart review, we identified a sensitivity and specificity of 78% (95% confidence interval [CI], 71.7-83.6%) and 99% (95% CI, 99.9-100%), respectively, for Algorithm 1 and 77% (95% CI, 70.7-82.9%) and 100% (95% CI, 100-100%) for Algorithm 2. We subsequently reviewed all cases that were misclassified by our algorithms. In total, there were 12 false negatives and 6 false positives (Table 4) . Those individuals misclassified as HIV-negative by both algorithms (false negatives) were missed due the critical diagnostic components of their records not being accessible to our algorithms, due to data being stored either in scanned form from an outside facility or in an outside EMR identified manually through Epic's Care Everywhere feature. Other misclassified results were due to incomplete metadata in our algorithms, with some individual HIV PCR results missed by our algorithm. Those individuals incorrectly classified as HIV-infected by the algorithms (false positives) were identified as such based on misclassification of medications prescribed for hepatitis B or PEP/PrEP as HIV treatment medications (Table 5) .
DISCUSSION
The widespread adoption of EMRs for clinical documentation in the United States has led to unprecedented opportunities for large-scale epidemiologic research. Traditional retrospective studies that previously took months or years to complete can now be performed in a fraction of the time. EMR-based computed phenotypes allow for rapid identification of patients, and have the added benefit of being adaptable to different health care systems, allowing for the development of multicenter cohorts of patients for research, clinical care, and public health initiatives. Computed phenotypes for disease case detection have been previously published for diabetes, cardiovascular disease, and asthma, with robust results. [2] [3] [4] In order to optimally utilize the benefits of these new systems for HIV research, we have developed novel computable phenotype algorithms to detect HIV-infected patients within a single institution. Our combined algorithms leverage the strengths of current guideline-based clinical diagnostic strategies while improving upon traditional chart review methodologies for case-finding by applying a multistep diagnostic approach. Implementing our algorithms to health system data identified a local estimated prevalence of HIV of 0.6%. This is consistent with the official estimate of HIV prevalence in Durham County, North Carolina, which in 2011 was reported to be 0.5%. 20, 21 Our novel algorithmic approach to the identification of HIV infection in an EMR system contributes to the current literature in several ways. Our objective of developing algorithms that can be applied to an entire nongovernmental health care system to create a virtual cohort of all individuals living with HIV infection is an approach with unique implications for research and clinical care. Similarly, our methodology of using a 2-step confirmation process instead of relying on administrative data alone improved the performance of our algorithms, as seen in Table 4 . Finally, combining a current guideline-based clinical approach with a non-laboratorybased 2-step confirmation pathway is unique to the published literature in the area and allowed for detection of cases in our cohort that would otherwise have been missed, representing an important population of individuals with fragmented health care access patterns.
When we compare the results of our current study to previous work by Goetz et al., our sensitivity for HIV case detection is lower. This was an intentional tradeoff for much higher specificity, which was the goal for our algorithms in the development phase. 8 This may also reflect differences in the objectives of each study. The Goetz study aimed to identify new diagnoses of HIV infection in a Veterans Health Administration cohort, whereas the goal of this study was to identify all patients with HIV infection in a nongovernment setting. 8 Applying our algorithms sequentially, we identified several issues that contribute to the misclassification of HIV infection status. The most common circumstance leading to mischaracterization of a patient as HIV-negative was incomplete metadata, where some medications and lab results were present in the chart but not identified by our algorithms. A secondary source of false negative results was identified if the diagnosis was obtained outside of our institution and listed solely in the narrative notes. This data could only be identified by manual extraction of data from the records. We also found that 4.2% of patients (6 out of 143) were misclassified as HIVinfected when they were actually HIV-negative. This was mainly secondary to antiretroviral medications used to treat hepatitis B or PEP, falsely categorizing patients as HIV-infected (Table 5) .
Our overall approach and final algorithms have several strengths. First, both an international guideline-based diagnostic approach and a more traditional ICD-9 code and billing information component were incorporated into the algorithm. Doing so allowed us to identify subjects that would have been missed by either algorithm alone. Second, the individual data components of our algorithm should be readily accessible for use in other health systems that have access to and experience using clinical data repositories by adapting individual algorithm components to local systems. The individual component domains of our algorithms (medications, ICD-9 codes, laboratory results) have been used by others in collaborative research, such as the Phenotype KnowledgeBase (PheKB) project from eMERGE creating EMR phenotypes for a variety of diseases. 22 It should be possible to take the individual components of our algorithm and build a PheKB HIV infection phenotype, which could then be implemented at partnering PheKB sites. Translation of our algorithms into a common data standard, either Observational Health Data Sciences and Informatics or an equivalent, may be necessary to permit portability between institutions. Finally, our study was performed in a large academic institution with experience in collecting data pre-and post-implementation of the Epic EMR. This setting allows for greater generalizability to other nongovernment health care systems that may use a similar medical record system.
There are limitations to our current approach. The initial review of the metadata failed to identify several laboratory results and medi- cations, yielding an inaccurate output that underestimated the prevalence of disease. A subsequent manual review of the data and software development was required to identify all pertinent lab and medication results missed. Moreover, there was difficulty interpreting the metadata output of laboratory tests due to confusion related to reference lab results, where multiple lines of redundant text were uploaded into the system and had to be manually reviewed and refined prior to being interpreted with our algorithm. Both of these issues may be unique to our local EMR implementation, and generalizability to other health care systems should be investigated. A further limitation involves our validation step results. Because of the small number of false negatives identified in our manual chart review, there is the potential to overestimate sensitivity with small changes in the number of false negatives. A final limitation is the changes in clinical practice since our cohort closed for enrollment in 2011. Since that time, billing has transitioned from ICD-9 to ICD-10, and new clinical diagnostic algorithms for HIV testing have been published. 5 Both of these changes should be accounted for as these algorithms are put into practice. Efforts are now being made to merge complementary diagnostic algorithms for other chronic diseases with our novel algorithms for HIV to develop a multitiered case finding system. By developing a repository of EMR phenotypes for different diagnoses with their associated test characteristics, we will be able to rapidly identify large cohorts of subjects with specific diagnoses accurately. Given the proliferation of EMRs across the United States, we anticipate that the process we have outlined can be readily adapted to other sites as well by using our completed algorithms as macro programs for statistical analysis software packages.
CONCLUSIONS
In this study, we have developed and validated novel HIV casedetection algorithms with good sensitivity and specificity. These novel algorithms allow for rapid case detection of HIV-infected individuals in large datasets using methodology that can be extrapolated to other health care systems, allowing for collaborative, crossinstitution cohort creation. While this represents a significant step forward, future studies should focus on applying these algorithms to multiple datasets and determining their test characteristics in different settings.
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